Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07210151 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anatomical Navigation for Guided Electrophysiology in AFL and AFib

Study acronym: ANGEL-AF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 38 days later Nov 1, 2026 → Dec 9, 2026
See other at-risk trials from LUMA Vision Ltd.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Nov 1, 2026 to Dec 9, 2026
    • Eligibility criteria expanded, about 10 words
  2. Study sites: 1 to 2v8
  3. Re-verified, no change to tracked fieldsv7
  4. Primary and study completion pushed from Oct 1, 2026 to Nov 1, 2026v6
  5. 2 versions Re-verified since Mar 9, 2026, no change to tracked fieldsv4-v5
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2026 to Jan 29, 2026
    v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to collect data on the use of the VERAFEYE Anatomical Guidance System in adult patients indicated to undergo a catheter ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). The study will collect specific information on management of AFL/AF ablation procedures with the commercial VERAFEYE Anatomical Guidance System including but not limited to acute procedural success , and how the VERAFEYE Anatomical Guidance System is used overall. Results from this study may be used to guide development and refinement the VERAFEYE Anatomical Guidance System.
Trial Details
NCT Number NCT07210151
Lead Sponsor LUMA Vision Ltd.
Conditions
(from sponsor)		 Atrial Fibrillation, Atrial Flutter, Atrial Arrhythmia
Related terms Atrial Fibrillation, Atrial Flutter
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov